32 results on '"Baloglu S"'
Search Results
2. EP13.01-002 Radiomic Signature on CT Images: A Noninvasive Biomarker for Pretreatment Discrimination of EGFR Mutations in NSCLC Patients
- Author
-
Kahya, Y., primary, Orhan, K., additional, Buyukceran, E.U., additional, Gumustepe, E., additional, Ozakinci, H., additional, Koksoy, E.B., additional, Ibrahimov, F., additional, Baloglu, S., additional, Coruh, A. Gursoy, additional, Akyurek, S., additional, Sak, S. Dizbay, additional, and Cangir, A. Kayi, additional
- Published
- 2022
- Full Text
- View/download PDF
3. FIRST REPORT OF GARLIC COMMON LATENT VIRUS IN GARLIC IN TURKEY
- Author
-
Fidan, H. and Baloglu, S.
- Published
- 2009
4. FIRST REPORT OF LEEK YELLOW STRIPE VIRUS ON LEEK IN TURKEY
- Author
-
Fidan, H. and Baloglu, S.
- Published
- 2009
5. PEAR, A NEW HOST OF APPLE CHLOROTIC LEAF SPOT VIRUS IN TURKEY
- Author
-
Koç, G., Bayırdar, L., and Baloglu, S.
- Published
- 2008
6. FIRST REPORT OF SHARKA IN THE ÇUKUROVA REGION OF TURKEY
- Author
-
Koç, G. and Baloglu, S.
- Published
- 2006
7. Coronavirus Disease 2019: Associated Multiple Organ Damage: Associated Multiple Organ Damage
- Author
-
Collange, O. (Olivier), Tacquard, C. (Charles), Delabranche, X. (Xavier), Leonard-Lorant, I. (Ian), Ohana, M. (Mickaël), Onea, M. (Mihaela), Anheim, M. (Mathieu), Solis, M. (Morgane), Sauer, A. (Arnaud), Baloglu, S. (Seyyid), Pessaux, P. (Patrick), Ohlmann, P. (Patrick), Kaeuffer, C. (Charlotte), Oulehri, W. (Walid), Kremer, S. (Stephane), and Mertes, P. (Paul-michel)
- Subjects
Sciences du Vivant [q-bio]/Médecine humaine et pathologie - Abstract
A 56-year-old man presented a particularly severe and multisystemic case of coronavirus disease 2019 (COVID-19). In addition to the common lung and quite common pulmonary embolism and kidney injuries, he presented ocular and intestinal injuries that, to our knowledge, have not been described in COVID-19 patients. Although it is difficult to make pathophysiological hypotheses about a single case, the multiplicity of injured organs argues for a systemic response to pulmonary infection. A better understanding of physiopathology should feed the discussion about therapeutic options in this type of multifocal damage related to severe acute respiratory syndrome coronavirus 2.
- Published
- 2020
8. Brain MRI Findings in Severe COVID-19: A Retrospective Observational Study
- Author
-
Kremer, S. (Stéphane), Boulay, C. (Clotilde), de Sèze, J. (Jérome), Ferré, J. (Jean-Christophe), Maamar, A. (Adel), Carsin-Nicol, B. (Béatrice), Collange, O. (Olivier), Bonneville, F. (Fabrice), Adam, G. (Gilles), Martin-Blondel, G. (Guillaume), Rafiq, M. (Marie), Geeraerts, T. (Thomas), Delamarre, L. (Louis), Grand, S. (Sylvie), Krainik, A. (Alexandre), Kremer, S. (Stephane), Alleg, M. (Manel), Anheim, M. (Mathieu), Anxionnat, R. (René), Ardellier, F. (François-Daniel), Baloglu, S. (Seyyid), Bapst, B. (Blanche), Benzakoun, J. (Joseph), Berge, J. (Jérome), Bolognini, F. (Federico), Bornet, G. (Grégoire), Boulouis, G. (Grégoire), Boutet, C. (Claire), Brisset, J. (Jean Christophe), Caillard-ohlmann, S. (Sophie), Carré, S. (Sophie), Comby, P. (Pierre-Olivier), Constans, J. (Jean Marc), David, J. (Jean-Stéphane), de Beaurepaire, I. (Isaure), De Seze, J. (Jerome), Desal, H. (Hubert), Edjlali-Goujon, M. (Myriam), Fabre, X. (Xavier), Fafi-Kremer, S. (Samira), Feuerstein, P. (Philippe), Henry Feugeas, M. (Marie-Cécile), Forestier, G. (Géraud), Gaudemer, A. (Augustin), Hansmann, Y. (Yves), Heintz, A. (Adrien), Boisrame, J. (Julie), Hemmert, C. (Céline), Hmeydia, G. (Ghazi), Jager, L. (Lavinia), Kazémi, A. (Apolline), Kerleroux, B. (Basile), Khalil, A. (Antoine), Lacalm, A. (Audrey), Lecler, A. (Augustin), Lecocq, C. (Claire), Lefebvre, N. (Nicolas), Lersy, F. (François), Matthieu, M. (Muriel), Megdiche, I. (Imen), Mertes, P. (Paul-michel), Messié, J. (Julien), Metanbou, S. (Serge), Meyer, N. (Nicolas), Meziani, F. (Ferhat), Mutschler, V. (Veronique), Nesser, P. (Patrick), Oesterlé, H. (Hélène), Ohana, M. (Mickaël), Oppenheim, C. (Catherine), Pyatigorskaya, N. (Nadya), Ricolfi, F. (Frédéric), Saleme, S. (Suzana), Schenck, M. (Maleka), Schmitt, E. (Emmanuelle), Schneider, F. (Francis), Sebag, N. (Nathan), Talla Mba, Y. (Yannick), Thouant, P. (Pierre), Willaume, T. (Thibault), Zhu, F. (François), Zorn, P. (Pierre-Emmanuel), Cotton, F. (François), Les Hôpitaux Universitaires de Strasbourg (HUS), Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie (ICube), Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Réseau nanophotonique et optique, Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Matériaux et nanosciences d'Alsace (FMNGE), Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Département de Radiologie [CHU de Rennes], Université de Rennes 1 (UR1), Université de Rennes (UNIV-RENNES)-Université de Rennes (UNIV-RENNES), Service des maladies infectieuses et réanimation médicale [Rennes] = Infectious Disease and Intensive Care [Rennes], CHU Pontchaillou [Rennes], CHU Toulouse [Toulouse], CHU Grenoble, Université Joseph Fourier - Grenoble 1 (UJF)-CHU Grenoble, Centre hospitalier de Haguenau, Institut de Génétique et de Biologie Moléculaire et Cellulaire (IGBMC), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Centre Hospitalier Universitaire de Nancy (CHU Nancy), CHU Henri Mondor, Institut de psychiatrie et neurosciences de Paris (IPNP - U1266 Inserm), Institut National de la Santé et de la Recherche Médicale (INSERM)-Université de Paris (UP), CHU Bordeaux [Bordeaux], Hôpitaux Civils de Colmar, Hôpital Privé d'Antony, Centre Hospitalier Universitaire de Saint-Etienne (CHU de Saint-Etienne), Observatoire Français de la Sclérose En Plaques [Lyon] (OFSEP), Immuno-Rhumatologie Moléculaire, Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), CHU Dijon, Centre Hospitalier Universitaire de Dijon - Hôpital François Mitterrand (CHU Dijon), CHU Amiens-Picardie, Hospices Civils de Lyon (HCL), Centre hospitalier universitaire de Nantes (CHU Nantes), Centre Hospitalier de Roanne (CH Roanne), CH de Roanne, Groupe hospitalier de la région de Mulhouse Sud-Alsace (GHRMSA), AP-HP - Hôpital Bichat - Claude Bernard [Paris], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP), CHU Limoges, CHU Strasbourg, Nouvel Hôpital Civil de Strasbourg, Université de Strasbourg (UNISTRA), Hôpital Marie-Madeleine [Forbach], CHU Lille, Hôpital de la Fondation Ophtalmologique Adolphe de Rothschild [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU), Les Hôptaux universitaires de Strasbourg (HUS), Nanomédecine Régénérative (NanoRegMed), Institut du Cerveau et de la Moëlle Epinière = Brain and Spine Institute (ICM), Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Centre de Recherche en Acquisition et Traitement de l'Image pour la Santé (CREATIS), Université Jean Monnet [Saint-Étienne] (UJM)-Hospices Civils de Lyon (HCL)-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université de Lyon-Institut National des Sciences Appliquées (INSA)-Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Centre National de la Recherche Scientifique (CNRS)-Institut National de la Santé et de la Recherche Médicale (INSERM), École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Université de Strasbourg (UNISTRA)-Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Centre National de la Recherche Scientifique (CNRS)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Réseau nanophotonique et optique, Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS), Université de Rennes (UR), Centre Hospitalier Universitaire de Toulouse (CHU Toulouse), CHU Henri Mondor [Créteil], Institut National de la Santé et de la Recherche Médicale (INSERM)-Université Paris Cité (UPCité), Centre Hospitalier Universitaire de Saint-Etienne [CHU Saint-Etienne] (CHU ST-E), Institut du Cerveau = Paris Brain Institute (ICM), Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Institut National de la Santé et de la Recherche Médicale (INSERM)-CHU Pitié-Salpêtrière [AP-HP], Assistance publique - Hôpitaux de Paris (AP-HP) (AP-HP)-Sorbonne Université (SU)-Sorbonne Université (SU)-Sorbonne Université (SU)-Centre National de la Recherche Scientifique (CNRS), Université Claude Bernard Lyon 1 (UCBL), Université de Lyon-Université de Lyon-Institut National des Sciences Appliquées de Lyon (INSA Lyon), Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Ferré, Jean-Christophe, and Université de Lyon-Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Hospices Civils de Lyon (HCL)-Université Jean Monnet - Saint-Étienne (UJM)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Adult ,Male ,medicine.medical_specialty ,Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] ,Adolescent ,Pneumonia, Viral ,Gastroenterology ,030218 nuclear medicine & medical imaging ,Temporal lobe ,White matter ,Cohort Studies ,03 medical and health sciences ,symbols.namesake ,Betacoronavirus ,Young Adult ,0302 clinical medicine ,Cerebrospinal fluid ,Internal medicine ,Intensive care ,medicine ,Humans ,Radiology, Nuclear Medicine and imaging ,10. No inequality ,Child ,Pandemics ,Fisher's exact test ,Aged ,Retrospective Studies ,medicine.diagnostic_test ,business.industry ,SARS-CoV-2 ,[SCCO.NEUR]Cognitive science/Neuroscience ,[SCCO.NEUR] Cognitive science/Neuroscience ,Brain ,COVID-19 ,Retrospective cohort study ,Magnetic resonance imaging ,Middle Aged ,medicine.disease ,Magnetic Resonance Imaging ,3. Good health ,Venous thrombosis ,medicine.anatomical_structure ,Neuroradiology ,030220 oncology & carcinogenesis ,symbols ,Female ,business ,Coronavirus Infections - Abstract
International audience; BackgroundBrain MRI parenchymal signal abnormalities have been associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2).PurposeTo describe the neuroimaging findings (excluding ischemic infarcts) in patients with severe coronavirus disease 2019 (COVID-19) infection.Materials and MethodsThis was a retrospective study of patients evaluated from March 23, 2020, to April 27, 2020, at 16 hospitals. Inclusion criteria were (a) positive nasopharyngeal or lower respiratory tract reverse transcriptase polymerase chain reaction assays, (b) severe COVID-19 infection defined as a requirement for hospitalization and oxygen therapy, (c) neurologic manifestations, and (d) abnormal brain MRI findings. Exclusion criteria were patients with missing or noncontributory data regarding brain MRI or brain MRI showing ischemic infarcts, cerebral venous thrombosis, or chronic lesions unrelated to the current event. Categorical data were compared using the Fisher exact test. Quantitative data were compared using the Student t test or Wilcoxon test. P < .05 represented a significant difference.ResultsThirty men (81%) and seven women (19%) met the inclusion criteria, with a mean age of 61 years ± 12 (standard deviation) (age range, 8–78 years). The most common neurologic manifestations were alteration of consciousness (27 of 37, 73%), abnormal wakefulness when sedation was stopped (15 of 37, 41%), confusion (12 of 37, 32%), and agitation (seven of 37, 19%). The most frequent MRI findings were signal abnormalities located in the medial temporal lobe in 16 of 37 patients (43%; 95% confidence interval [CI]: 27%, 59%), nonconfluent multifocal white matter hyperintense lesions seen with fluid-attenuated inversion recovery and diffusion-weighted sequences with variable enhancement, with associated hemorrhagic lesions in 11 of 37 patients (30%; 95% CI: 15%, 45%), and extensive and isolated white matter microhemorrhages in nine of 37 patients (24%; 95% CI: 10%, 38%). A majority of patients (20 of 37, 54%) had intracerebral hemorrhagic lesions with a more severe clinical presentation and a higher admission rate in intensive care units (20 of 20 patients [100%] vs 12 of 17 patients without hemorrhage [71%], P = .01) and development of the acute respiratory distress syndrome (20 of 20 patients [100%] vs 11 of 17 patients [65%], P = .005). Only one patient had SARS-CoV-2 RNA in the cerebrospinal fluid.ConclusionPatients with severe coronavirus disease 2019 and without ischemic infarcts had a wide range of neurologic manifestations that were associated with abnormal brain MRI scans. Eight distinctive neuroradiologic patterns were described.
- Published
- 2020
9. Guillain-Barré syndrome related to SARS-CoV-2 infection
- Author
-
Bigaut, K. (Kévin), Mallaret, M. (Martial), Baloglu, S. (Seyyid), Nemoz, B. (Benjamin), Morand, P. (Patrice), Baicry, F. (Florent), Godon, A. (Alexandre), Voulleminot, P. (Paul), Kremer, L. (Laurent), Chanson, J. (Jean-Baptiste), and De Sèze, J. (Jérôme)
- Subjects
Sciences du Vivant [q-bio]/Médecine humaine et pathologie - Published
- 2020
10. Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD)
- Author
-
Bigaut, K. (Kévin), Achard, S. (Sophie), Hemmert, C. (Céline), Baloglu, S. (Seyyid), Kremer, L. (Laurent), Collongues, N. (Nicolas), De Seze, J. (Jerome), Kremer, S. (Stephane), De Vico Fallani, F. (Fabrizio) (editor), GIPSA - Communication Information and Complex Systems (GIPSA-CICS), Département Images et Signal (GIPSA-DIS), Grenoble Images Parole Signal Automatique (GIPSA-lab ), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Grenoble Images Parole Signal Automatique (GIPSA-lab ), Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019])-Institut polytechnique de Grenoble - Grenoble Institute of Technology (Grenoble INP )-Institut Polytechnique de Grenoble - Grenoble Institute of Technology-Centre National de la Recherche Scientifique (CNRS)-Université Grenoble Alpes [2016-2019] (UGA [2016-2019]), Biopathologie de la Myéline, Neuroprotection et Stratégies Thérapeutiques (BMNST), Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM), Laboratoire des sciences de l'ingénieur, de l'informatique et de l'imagerie (ICube), Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)-École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Réseau nanophotonique et optique, Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Matériaux et nanosciences d'Alsace (FMNGE), Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS)-Institut de Chimie du CNRS (INC)-Université de Strasbourg (UNISTRA)-Institut National de la Santé et de la Recherche Médicale (INSERM)-Centre National de la Recherche Scientifique (CNRS), Les Hôpitaux Universitaires de Strasbourg (HUS), GIPSA - Vision and Brain Signal Processing (GIPSA-VIBS), Groupe hospitalier de la région de Mulhouse et Sud-Alsace, École Nationale du Génie de l'Eau et de l'Environnement de Strasbourg (ENGEES)-Université de Strasbourg (UNISTRA)-Institut National des Sciences Appliquées - Strasbourg (INSA Strasbourg), Institut National des Sciences Appliquées (INSA)-Institut National des Sciences Appliquées (INSA)-Institut National de Recherche en Informatique et en Automatique (Inria)-Les Hôpitaux Universitaires de Strasbourg (HUS)-Centre National de la Recherche Scientifique (CNRS)-Matériaux et Nanosciences Grand-Est (MNGE), Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Institut National de la Santé et de la Recherche Médicale (INSERM)-Institut de Chimie du CNRS (INC)-Centre National de la Recherche Scientifique (CNRS)-Réseau nanophotonique et optique, and Université de Strasbourg (UNISTRA)-Université de Haute-Alsace (UHA) Mulhouse - Colmar (Université de Haute-Alsace (UHA))-Centre National de la Recherche Scientifique (CNRS)-Université de Strasbourg (UNISTRA)-Centre National de la Recherche Scientifique (CNRS)
- Subjects
Male ,Central Nervous System ,Global Health ,Topology ,Nervous System ,030218 nuclear medicine & medical imaging ,Diagnostic Radiology ,Correlation ,0302 clinical medicine ,Functional Magnetic Resonance Imaging ,Medicine and Health Sciences ,Spectrum disorder ,Public and Occupational Health ,ComputingMilieux_MISCELLANEOUS ,Brain Mapping ,Multidisciplinary ,medicine.diagnostic_test ,Radiology and Imaging ,Neuromyelitis Optica ,Brain ,Neurodegenerative Diseases ,Middle Aged ,Magnetic Resonance Imaging ,Neurology ,Physical Sciences ,Medicine ,Female ,[SDV.NEU]Life Sciences [q-bio]/Neurons and Cognition [q-bio.NC] ,Anatomy ,Research Article ,Adult ,Computer and Information Sciences ,Multiple Sclerosis ,Sciences du Vivant [q-bio]/Neurosciences [q-bio.NC] ,Patients ,Neural Networks ,Imaging Techniques ,Science ,Rest ,Immunology ,Neuroimaging ,Research and Analysis Methods ,Autoimmune Diseases ,03 medical and health sciences ,Diagnostic Medicine ,Echo Planar Imaging ,Neuroplasticity ,medicine ,Humans ,Aged ,Expanded Disability Status Scale ,Neuromyelitis optica ,Resting state fMRI ,business.industry ,Multiple sclerosis ,Biology and Life Sciences ,medicine.disease ,Demyelinating Disorders ,Health Care ,Case-Control Studies ,Clinical Immunology ,Clinical Medicine ,Functional magnetic resonance imaging ,business ,Neuroscience ,030217 neurology & neurosurgery ,Mathematics - Abstract
Background The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains unclear. Objective Compare brain functional connectivity of patients with NMOSD to healthy subjects in resting-state functional MRI (rs-fMRI). Methods We compared the rs-fMRI connectivity in 12 NMOSD patients with 20 healthy subjects matched for age and sex. Graph theory analysis was used to quantify the role of each node using a set of metrics: degree, global efficiency, clustering and modularity. To summarize the abnormal connectivity profile of brain regions in patients compared to healthy subjects, we defined a hub disruption index κ. Results Concerning the global organization of networks in NMOSD, a small-world topology was preserved without significant modification concerning all average metrics. However, visual networks and the sensorimotor network showed decreased connectivity with high interindividual variability. The hub disruption index κ was correlated to the Expanded Disability Status Scale (EDSS). Conclusion These results demonstrate a correlation between disability according to the EDSS and neuronal reorganization using the rs-fMRI graph methodology. The conservation of a normal global topological structure despite local modifications in functional connectivity seems to show brain plasticity in response to the disability.
- Published
- 2019
11. First outbreak and occurrence of citrus blast disease, caused by Pseudomonas syringae pv. syringae, on orange and mandarin trees in Turkey
- Author
-
Mirik, M., Baloglu, S., Aysan, Y., Cetinkaya-Yildiz, R., Kusek, M., and Sahin, F.
- Published
- 2005
12. Ultrastructural observations on virus-diseased plants from Western Turkey
- Author
-
Martelli, G.P., Yilmaz, M.A., and Baloglu, S.
- Published
- 1984
13. Handbook of Scales in Tourism and Hospitality Research
- Author
-
Gursoy, D, Uysal, M., Sirakaya-Turk, E., Ekinci, Y., Baloglu, S., Gursoy, D, Uysal, M., Sirakaya-Turk, E., Ekinci, Y., and Baloglu, S.
- Abstract
By introducing the importance of measurement and scales and providing groupings of existing scales The Handbook of Scales in Tourism and Hospitality Research serves as the state of the art reference book in the field of tourism, hospitality ...
- Published
- 2015
14. First Report of Onion yellow dwarf virus and Leek yellow stripe virus in Garlic in Turkey
- Author
-
Fidan, H., primary and Baloglu, S., additional
- Published
- 2009
- Full Text
- View/download PDF
15. First report ofChondrostereum purpureumcausing silverleaf disease of apricot(Prunus armeniaca)in Malatya, Turkey
- Author
-
Ozgonen, H., primary, Erkilic, A., additional, Koc, G., additional, and Baloglu, S., additional
- Published
- 2006
- Full Text
- View/download PDF
16. Structural examination to the adverbs in Omer Seyfettin’s stories
- Author
-
Baloğlu S.
- Subjects
International relations ,JZ2-6530 - Abstract
Our Turkish language, which offers all the possibilities of its circumstances limitless, opens different perspective to us as it reaches its profoundness. Any research on language, progress, and every conclusion reached in different subjects did not allow the final point in linguistics as in other sciences. It has also been the basis of useful linguistic works that have been continuing and continuing until now. In our article, as Omer Seyfettin’s word types in the sentences chosen from the stories are evaluated separately, the adverbs which are widely used in Turkish language are examined structurally. When this and such works are done and will be done, the writers and poets who have produced outstanding works in the field of summer will be exposed to their skillful use of language and rich vocabulary. Our aim is to show the skill of Turkish writer Omer Seyfettin in using the language and to announce to the Turkish world countries and the world. Key words: Turkish language, story, Omer Seyfettin, linguistics, adverb.
- Published
- 2020
17. Certification of citrus in Turkey
- Author
-
Baloglu, S. and Baloglu, S.
18. First report of Chondrostereum purpureum causing silverleaf disease of apricot (Prunus armeniaca) in Malatya, Turkey.
- Author
-
Ozgonen, H., Erkilic, A., Koc, G., and Baloglu, S.
- Subjects
APRICOT ,AGRICULTURAL economics ,PRUNUS ,PLANT diseases - Abstract
Apricot (Prunus armeniaca) is important in the economy of Turkey. Chondrostereum purpureum causing silvering was observed in apricot growing areas in Malatya, Turkey. The characteristic symptom of the diseased tree was silvering of leaves resulting from fungal toxin. The disease incidence was found to be 2-15% in surveyed areas. The pathogenicity test was undertaken on apricot trees in a nursery, and disease incidence was found to be 22% after inoculation. [ABSTRACT FROM AUTHOR]
- Published
- 2006
- Full Text
- View/download PDF
19. First outbreak and occurrence of citrus blast disease, caused byPseudomonas syringaepv.syringae, on orange and mandarin trees in Turkey.
- Author
-
Mirik, M., Baloglu, S., Aysan, Y., Cetinkaya-Yildiz, R., Kusek, M., and Sahin, F.
- Subjects
- *
PSEUDOMONAS syringae , *PETIOLES , *LEAVES , *TWIGS , *PLANT shoots , *PLANT diseases - Abstract
The article reports on the occurrence of citrus blast disease, caused by Pseudomonas syringae on orange and mandarin trees in Turkey. Characteristic disease symptoms were first seen on leaves as watersoaked lesions and black areas on the petiole wings. Later lesions extended to the mid-vein of leaves and to the twigs surrounding the base of the petiole. The necrotic areas on twigs further enlarged and the twigs were eventually killed within 20-30 days. The test results conformed to the characteristics of Pseudomonas syringae as the causal organism of citrus blast and were similar to those of reference strain.
- Published
- 2005
- Full Text
- View/download PDF
20. First outbreak and occurrence of citrus blast disease, caused by Pseudomonas syringae pv. syringae, on orange and mandarin trees in Turkey
- Author
-
Fikrettin Şahin, S. Baloglu, Mustafa Küsek, R. Cetinkaya-Yildiz, Yeşim Aysan, Mustafa Mirik, Çukurova Üniversitesi, Mirik, M., Baloglu, S., Aysan, Y., Cetinkaya-Yildiz, R., Kusek, M., Şahin, Fikrettin, and Yeditepe Üniversitesi
- Subjects
biology ,Inoculation ,Nicotiana tabacum ,Outbreak ,Plant Science ,Orange (colour) ,Horticulture ,biology.organism_classification ,Petiole (botany) ,Botany ,Genetics ,Pseudomonas syringae ,medicine ,Mannitol ,Agronomy and Crop Science ,Bacteria ,medicine.drug - Abstract
In the spring of 2004, severe outbreaks of a disease resembling citrus blast (Whiteside et al ., 1988), were observed on trees of orange ( Citrus cinensis cv. Washington) and mandarin ( Citrus rediculate cv. Marisol) in the Turkish Mediterranean regions of Adana and Antalya. Characteristic disease symptoms were first seen on leaves as watersoaked lesions and black areas on the petiole wings. Later lesions extended to the mid-vein of leaves and to the twigs surrounding the base of the petiole. Finally, the leaves dried and rolled, while still firmly attached, before eventually dropping without petioles. The necrotic areas on twigs further enlarged and the twigs were eventually killed within 20‐30 days. The damage was serious in a 50-hectare citrus orchard in Antalya, with a disease incidence of nearly 100%. Twelve isolates of a bacterium, consistently isolated from infected leaves, petioles and twigs, which formed fluorescent colonies on King’s medium B, were purified and used for further studies. All isolates were Gram-, oxidase-, pectolytic activity-, starch hydrolase-, arginine dihydrolase- and nitrate reduction-negative; and levan-, gelatin hydrolase-positive. They produced hypersensitive reactions (positive) on tobacco leaves ( Nicotiana tabacum cv. Samsun N.). All produced acid from glucose, glycerine, arabinose, mannitol, sorbitol, sucrose and xylose but not from lactose and maltose. The test results conformed to the characteristics of P. syringae pv. syringae (Braun-Kiewnick & Sands, 2001) as the causal organism of citrus blast and were similar to those of reference strain NCPPB 2307 of P. syringae pv. syringae used in this study. Fatty acid analysis (Ataturk University, Erzurum, Turkey) confirmed the bacterial strains as P. syringae pv. syringae with similarity indices of 81‐94%. Pathogenicity of the strains was tested on 1-year-old mandarin. Inoculations were made, using a hypodermic needle with a suspension of bacteria in a saline buffer (10 8
- Published
- 2005
21. Outcomes of Patients with Non-Small Cell Lung Cancer and Brain Metastases Treated with the Upfront Single Agent Pembrolizumab: A Retrospective and Multicentric Study of the ESCKEYP GFPC Cohort.
- Author
-
Nannini S, Guisier F, Curcio H, Ricordel C, Demontrond P, Abdallahoui S, Baloglu S, Greillier L, Chouaid C, and Schott R
- Subjects
- Humans, Retrospective Studies, Carcinoma, Non-Small-Cell Lung drug therapy, Lung Neoplasms drug therapy, Antineoplastic Agents, Immunological therapeutic use, Brain Neoplasms, Antibodies, Monoclonal, Humanized
- Abstract
Non-small cell lung cancer (NSCLC) is the most common cause of brain metastasis (BM). Little is known about immune checkpoint inhibitor activity in the central nervous system, especially in patients receiving monotherapy for tumors with a tumor proportion score (TPS) ≥ 50%. This noninterventional, retrospective, multicenter study, conducted with the GFPC, included treatment-naïve patients strongly positive for PD-L1 (TPS ≥ 50%) with BM receiving first-line single-agent pembrolizumab treatment between May 2017 and November 2019. The primary endpoints were centrally reviewed intracranial overall response rates (ORRs), centrally reviewed intracranial progression-free survival (cPFS), extracranial PFS, and overall survival were secondary endpoints. Forty-three patients from five centers were included. Surgical or local radiation therapy was administered to 31 (72%) patients, mostly before initiating ICI therapy (25/31). Among 38/43 (88.4%) evaluable patients, the intracranial ORR was 73%. The median PFS was 8.3 months. The cerebral and extracerebral median PFS times were 9.2 and 5.3 months, respectively. The median OS was 25.5 months. According to multivariate analysis, BM surgery before ICI therapy was the only factor significantly associated with both improved PFS (HR = 0.44) and OS (HR = 0.45). This study revealed the feasibility and outcome of front-line pembrolizumab treatment in this population with BM.
- Published
- 2024
- Full Text
- View/download PDF
22. Pituitary Abscess: A Challenging Preoperative Diagnosis-A Multicenter Study.
- Author
-
Mallereau CH, Todeschi J, Ganau M, Cebula H, Bozzi MT, Romano A, Le Van T, Ollivier I, Zaed I, Spatola G, Nannavecchia B, Mahoudeau P, Djennaoui I, Debry C, Signorelli F, Ligarotti GKI, Pop R, Baloglu S, Fasciglione E, Goichot B, Bund C, Gaudias J, Proust F, and Chibbaro S
- Subjects
- Humans, Abscess, Pituitary Gland pathology, Headache, Magnetic Resonance Imaging, Pituitary Diseases complications, Pituitary Diseases diagnosis, Pituitary Diseases surgery, Pituitary Neoplasms complications, Pituitary Neoplasms diagnosis, Pituitary Neoplasms surgery
- Abstract
Background and Objectives: Pituitary abscess (PA) is a rare occurrence, representing less than 1% of pituitary lesions, and is defined by the presence of an infected purulent collection within the sella turcica. Pas can be classified as either primary, when the underlying pituitary is normal prior to infection, or secondary, when there is associated a pre-existing sellar pathology (i.e., pituitary adenoma, Rathke's cleft cysts, or craniopharyngioma), with or without a recent history of surgery. Preoperative diagnosis, owing to both non-specific symptoms and imaging features, remains challenging. Treatment options include endonasal trans-sphenoidal pus evacuation, as well as culture and tailored antibiotic therapy. Methods: A retrospective multicenter study, conducted on a prospectively built database over a 20-year period, identified a large series of 84 patients harboring primary sellar abscess. The study aimed to identify crucial clinical and imaging features in order to accelerate appropriate management. Results : The most common clinical presentation was a symptom triad consisting of various degrees of asthenia (75%), visual impairment (71%), and headache (50%). Diagnosis was achieved in 95% of cases peri- or postoperatively. Functional recovery was good for visual disturbances and headache. Pituitary function recovery remained very poor (23%), whereas the preoperative diagnosis represented a protective factor. Conclusions : In light of the high prevalence of pituitary dysfunction following the management of PAs, early diagnosis and treatment might represent a crucial issue. Currently, there are no standard investigations to establish a conclusive preoperative diagnosis; however, new, emerging imaging methods, in particular nuclear imaging modalities, represent a very promising tool, whose potential warrants further investigations.
- Published
- 2023
- Full Text
- View/download PDF
23. Evolution of Neuroimaging Findings in Severe COVID-19 Patients with Initial Neurological Impairment: An Observational Study.
- Author
-
Lersy F, Bund C, Anheim M, Mondino M, Noblet V, Lazzara S, Phillipps C, Collange O, Oulehri W, Mertes PM, Helms J, Merdji H, Schenck M, Schneider F, Pottecher J, Giraudeau C, Chammas A, Ardellier FD, Baloglu S, Ambarki K, Namer IJ, and Kremer S
- Subjects
- Female, Fluorodeoxyglucose F18, Humans, Male, Middle Aged, Neuroimaging, Positron Emission Tomography Computed Tomography, COVID-19 diagnostic imaging, Vasculitis, Central Nervous System
- Abstract
Background and Objectives: Cerebral complications related to the COVID-19 were documented by brain MRIs during the acute phase. The purpose of the present study was to describe the evolution of these neuroimaging findings (MRI and FDG-PET/CT) and describe the neurocognitive outcomes of these patients., Methods: During the first wave of the COVID-19 outbreak between 1 March and 31 May 2020, 112 consecutive COVID-19 patients with neurologic manifestations underwent a brain MRI at Strasbourg University hospitals. After recovery, during follow-up, of these 112 patients, 31 (initially hospitalized in intensive care units) underwent additional imaging studies (at least one brain MRI)., Results: Twenty-three men (74%) and eight women (26%) with a mean age of 61 years (range: 18-79) were included. Leptomeningeal enhancement, diffuse brain microhemorrhages, acute ischemic strokes, suspicion of cerebral vasculitis, and acute inflammatory demyelinating lesions were described on the initial brain MRIs. During follow-up, the evolution of the leptomeningeal enhancement was discordant, and the cerebral microhemorrhages were stable. We observed normalization of the vessel walls in all patients suspected of cerebral vasculitis. Four patients (13%) demonstrated new complications during follow-up (ischemic strokes, hypoglossal neuritis, marked increase in the white matter FLAIR hyperintensities with presumed vascular origin, and one suspected case of cerebral vasculitis). Concerning the grey matter volumetry, we observed a loss of volume of 3.2% during an average period of approximately five months. During follow-up, the more frequent FDG-PET/CT findings were hypometabolism in temporal and insular regions., Conclusion: A minority of initially severe COVID-19 patients demonstrated new complications on their brain MRIs during follow-up after recovery.
- Published
- 2022
- Full Text
- View/download PDF
24. Primary Endoscopic Endonasal Management of Giant Pituitary Adenomas: Outcome and Pitfalls from a Large Prospective Multicenter Experience.
- Author
-
Chibbaro S, Signorelli F, Milani D, Cebula H, Scibilia A, Bozzi MT, Messina R, Zaed I, Todeschi J, Ollivier I, Mallereau CH, Dannhoff G, Romano A, Cammarota F, Servadei F, Pop R, Baloglu S, Lasio GB, Luca F, Goichot B, Proust F, and Ganau M
- Abstract
Purpose: To evaluate factors influencing clinical and radiological outcome of extended endoscopic endonasal transtuberculum/transplanum approach (EEA-TTP) for giant pituitary adenomas (GPAs)., Methods: We recruited prospectively all consecutive GPAs patients undergoing EEA-TTP between 2015 and 2019 in 5 neurosurgical centers. Preoperative clinical and radiologic features, visual and hormonal outcomes, extent of resection (EoR), complications and recurrence rates were recorded and analyzed., Results: Of 1169 patients treated for pituitary adenoma, 96 (8.2%) had GPAs. Seventy-eight (81.2%) patients had visual impairment, 12 (12.5%) had headaches, 3 (3.1%) had drowsiness due to hydrocephalus, and 53 (55.2%) had anterior pituitary insufficiency. EoR was gross or near-total in 46 (47.9%) and subtotal in 50 (52.1%) patients. Incomplete resection was associated with lateral suprasellar, intraventricular and/or cavernous sinus extension and with firm/fibrous consistence. At the last follow-up, all but one patient (77, 98.7%) with visual deficits improved. Headache improved in 8 (88.9%) and anterior pituitary function recovered in 27 (50.9%) patients. Recurrence rate was 16.7%, with 32 months mean recurrence-free survival., Conclusions: EEA-TTP is a valid option for GPAs and seems to provide better outcomes, lower rate of complications and higher EoR compared to one- or multi-stage microscopic, non-extended endoscopic transsphenoidal, and transcranial resections.
- Published
- 2021
- Full Text
- View/download PDF
25. Coronavirus Disease 2019: Associated Multiple Organ Damage.
- Author
-
Collange O, Tacquard C, Delabranche X, Leonard-Lorant I, Ohana M, Onea M, Anheim M, Solis M, Sauer A, Baloglu S, Pessaux P, Ohlmann P, Kaeuffer C, Oulehri W, Kremer S, and Mertes PM
- Abstract
A 56-year-old man presented a particularly severe and multisystemic case of coronavirus disease 2019 (COVID-19). In addition to the common lung and quite common pulmonary embolism and kidney injuries, he presented ocular and intestinal injuries that, to our knowledge, have not been described in COVID-19 patients. Although it is difficult to make pathophysiological hypotheses about a single case, the multiplicity of injured organs argues for a systemic response to pulmonary infection. A better understanding of physiopathology should feed the discussion about therapeutic options in this type of multifocal damage related to severe acute respiratory syndrome coronavirus 2., (© The Author(s) 2020. Published by Oxford University Press on behalf of Infectious Diseases Society of America.)
- Published
- 2020
- Full Text
- View/download PDF
26. Guillain-Barré syndrome related to SARS-CoV-2 infection.
- Author
-
Bigaut K, Mallaret M, Baloglu S, Nemoz B, Morand P, Baicry F, Godon A, Voulleminot P, Kremer L, Chanson JB, and de Seze J
- Subjects
- Adult, Aged, Ageusia etiology, Asthenia etiology, Ataxia etiology, COVID-19, Coronavirus Infections complications, Diarrhea etiology, Facial Paralysis etiology, Female, Guillain-Barre Syndrome cerebrospinal fluid, Guillain-Barre Syndrome complications, Guillain-Barre Syndrome therapy, Humans, Immunoglobulins, Intravenous therapeutic use, Immunologic Factors therapeutic use, Male, Middle Aged, Myalgia etiology, Neural Conduction, Olfaction Disorders etiology, Pandemics, Paraparesis etiology, Paresthesia etiology, Pneumonia, Viral complications, Quadriplegia etiology, Reflex, Abnormal, Respiratory Insufficiency etiology, Coronavirus Infections physiopathology, Guillain-Barre Syndrome physiopathology, Pneumonia, Viral physiopathology
- Published
- 2020
- Full Text
- View/download PDF
27. Multinodular and Vacuolating Posterior Fossa Lesions of Unknown Significance.
- Author
-
Lecler A, Bailleux J, Carsin B, Adle-Biassette H, Baloglu S, Bogey C, Bonneville F, Calvier E, Comby PO, Cottier JP, Cotton F, Deschamps R, Diard-Detoeuf C, Ducray F, Duron L, Drissi C, Elmaleh M, Farras J, Garcia JA, Gerardin E, Grand S, Jianu DC, Kremer S, Magne N, Mejdoubi M, Moulignier A, Ollivier M, Nagi S, Rodallec M, Sadik JC, Shor N, Tourdias T, Vandendries C, Broquet V, and Savatovsky J
- Subjects
- Adult, Aged, Brain pathology, Female, Humans, Magnetic Resonance Imaging methods, Male, Middle Aged, Young Adult, Infratentorial Neoplasms diagnostic imaging, Infratentorial Neoplasms pathology
- Abstract
Multinodular and vacuolating neuronal tumor of the cerebrum is a rare supratentorial brain tumor described for the first time in 2013. Here, we report 11 cases of infratentorial lesions showing similar striking imaging features consisting of a cluster of low T1-weighted imaging and high T2-FLAIR signal intensity nodules, which we referred to as multinodular and vacuolating posterior fossa lesions of unknown significance. No relationship was found between the location of the lesion and clinical symptoms. A T2-FLAIR hypointense central dot sign was present in images of 9/11 (82%) patients. Cortical involvement was present in 2/11 (18%) of patients. Only 1 nodule of 1 multinodular and vacuolating posterior fossa lesion of unknown significance showed enhancement on postcontrast T1WI. DWI, SWI, MRS, and PWI showed no malignant pattern. Lesions did not change in size or signal during a median follow-up of 3 years, suggesting that multinodular and vacuolating posterior fossa lesions of unknown significance are benign malformative lesions that do not require surgical intervention or removal., (© 2019 by American Journal of Neuroradiology.)
- Published
- 2019
- Full Text
- View/download PDF
28. Detection and characterization of citrus tatter leaf virus (CTLV) and citrus yellow vein clearing virus (CYVCV) in citrus trees from Cyprus.
- Author
-
Alas T, Baloglu S, Caglar BK, and Gunes A
- Abstract
Citrus tatter leaf virus (CTLV) was firstly reported of in California. After that, it reported in Australia, Korea, Nigeria, Japan, South Africa, and China. The transmission of this virus from plant to plant is very easy with mechanically. Citrus yellow vein clearing virus (CYVCV) was reported on lemon trees in India, Pakistan, Turkey and China. Foliar distortion, necrotic spots, chlorosis and wrinkling symptoms were observed in young lemon orchards in newly established orchards with trees imported from abroad. Therefore, surveys of citrus trees in Cyprus were performed for CTLV and CYVCV from 2013 to 2016. A total of 64 leaf samples from symptomatic citrus trees (41 lemon, 10 orange, 10 mandarin and three grapefruit samples) were collected for total nucleic acid extraction and RT-PCR with CTLV primers to amplify a 309 bp and a 614 bp fragment, respectively, of the 5' end (100%) and high nucleotide sequence identity (99%) with isolates BJNM-2 and QC4 from China and isolate BDZ-1 from Australia. To our knowledge, this is the first report of CTLV from Europe.
- Published
- 2019
- Full Text
- View/download PDF
29. Grade III meningioma with gastro-intestinal tract and brain metastases: case report and review of the literature.
- Author
-
Bender L, Lhermitte B, Carinato H, Baloglu S, Helali M, Cebula H, Antoni D, and Noel G
- Subjects
- Aged, Brain Neoplasms therapy, Gastrointestinal Neoplasms therapy, Humans, Male, Meningeal Neoplasms therapy, Meningioma therapy, Neoplasm Grading, Brain Neoplasms secondary, Gastrointestinal Neoplasms secondary, Meningeal Neoplasms pathology, Meningioma pathology
- Abstract
Background: Meningioma is the most common adult primary intracranial tumor. Malignant meningioma is a rare variant of meningioma. The prognosis for the patients with these tumors is poor, due to the tumor's capacity for relapse and to develop distant metastases. These tumors can present the same evolutionary course as aggressive carcinoma., Case Description: We report the case of distant brain and gastro-intestinal tract (GIT) metastases. A 78-year-old patient developed malignant meningioma with a Ki-67 proliferative index of 40%. According to guidelines, surgery followed by postoperative radiotherapy (RT) was performed. Three months after the end of RT, he presented histologically proven meningioma distant brain and GIT metastases., Conclusions: To our knowledge, this is the first case of meningioma GIT metastases. Also, we report the difficulty to confirm the diagnosis of meningioma metastases. Indeed, malignant meningioma has the same histopathological features as melanoma or carcinoma. The standard of care for the management of malignant meningioma is gross total surgery followed by postoperative radiotherapy. Metastatic meningioma is uncommon and no guidelines for the management of recurrent or metastatic meningioma have yet been published. However, several studies reported systemic therapeutic options such as antibody against VEGF, somatostatin analogs, PDGF-R, and VEGF-R tyrosine kinase inhibitors, in the case of recurrent or metastatic meningioma. We also made a review of the actual literature of systemic treatment options for metastatic meningioma.
- Published
- 2019
- Full Text
- View/download PDF
30. Resting-state functional MRI demonstrates brain network reorganization in neuromyelitis optica spectrum disorder (NMOSD).
- Author
-
Bigaut K, Achard S, Hemmert C, Baloglu S, Kremer L, Collongues N, De Sèze J, and Kremer S
- Subjects
- Adult, Aged, Case-Control Studies, Female, Humans, Male, Middle Aged, Brain physiology, Brain Mapping methods, Magnetic Resonance Imaging methods, Neuromyelitis Optica physiopathology, Rest physiology
- Abstract
Background: The relation between brain functional connectivity of patients with neuromyelitis optica spectrum disorder (NMOSD) and the degree of disability remains unclear., Objective: Compare brain functional connectivity of patients with NMOSD to healthy subjects in resting-state functional MRI (rs-fMRI)., Methods: We compared the rs-fMRI connectivity in 12 NMOSD patients with 20 healthy subjects matched for age and sex. Graph theory analysis was used to quantify the role of each node using a set of metrics: degree, global efficiency, clustering and modularity. To summarize the abnormal connectivity profile of brain regions in patients compared to healthy subjects, we defined a hub disruption index κ., Results: Concerning the global organization of networks in NMOSD, a small-world topology was preserved without significant modification concerning all average metrics. However, visual networks and the sensorimotor network showed decreased connectivity with high interindividual variability. The hub disruption index κ was correlated to the Expanded Disability Status Scale (EDSS)., Conclusion: These results demonstrate a correlation between disability according to the EDSS and neuronal reorganization using the rs-fMRI graph methodology. The conservation of a normal global topological structure despite local modifications in functional connectivity seems to show brain plasticity in response to the disability., Competing Interests: The authors have declared that no competing interests exist.
- Published
- 2019
- Full Text
- View/download PDF
31. Immunogenicity and efficacy of intramuscular replication-defective and subunit vaccines against herpes simplex virus type 2 in the mouse genital model.
- Author
-
Delagrave S, Hernandez H, Zhou C, Hamberger JF, Mundle ST, Catalan J, Baloglu S, Anderson SF, DiNapoli JM, Londoño-Hayes P, Parrington M, Almond J, and Kleanthous H
- Subjects
- Adjuvants, Immunologic administration & dosage, Alum Compounds administration & dosage, Animals, Antibodies, Neutralizing blood, Antibodies, Neutralizing immunology, Antibodies, Viral blood, Antibodies, Viral immunology, Disease Models, Animal, Female, Ganglia, Spinal virology, Herpes Genitalis immunology, Herpes Simplex Virus Vaccines immunology, Humans, Injections, Intramuscular, Mice, Mice, Inbred BALB C, Oligodeoxyribonucleotides administration & dosage, Vaccines, Attenuated administration & dosage, Vaccines, Attenuated immunology, Vaccines, Subunit administration & dosage, Vaccines, Subunit immunology, Vagina virology, Viral Envelope Proteins administration & dosage, Viral Envelope Proteins immunology, Herpes Genitalis prevention & control, Herpes Simplex Virus Vaccines administration & dosage, Herpesvirus 2, Human immunology
- Abstract
Herpes simplex virus type 2 (HSV-2) is a sexually transmitted virus that is highly prevalent worldwide, causing a range of symptoms that result in significant healthcare costs and human suffering. ACAM529 is a replication-defective vaccine candidate prepared by growing the previously described dl5-29 on a cell line appropriate for GMP manufacturing. This vaccine, when administered subcutaneously, was previously shown to protect mice from a lethal vaginal HSV-2 challenge and to afford better protection than adjuvanted glycoprotein D (gD) in guinea pigs. Here we show that ACAM529 given via the intramuscular route affords significantly greater immunogenicity and protection in comparison with subcutaneous administration in the mouse vaginal HSV-2 challenge model. Further, we describe a side-by-side comparison of intramuscular ACAM529 with a gD vaccine across a range of challenge virus doses. While differences in protection against death are not significant, ACAM529 protects significantly better against mucosal infection, reducing peak challenge virus shedding at the highest challenge dose by over 500-fold versus 5-fold for gD. Over 27% (11/40) of ACAM529-immunized animals were protected from viral shedding while 2.5% (1/40) were protected by the gD vaccine. Similarly, 35% (7/20) of mice vaccinated with ACAM529 were protected from infection of their dorsal root ganglia while none of the gD-vaccinated mice were protected. These results indicate that measuring infection of the vaginal mucosa and of dorsal root ganglia over a range of challenge doses is more sensitive than evaluating survival at a single challenge dose as a means of directly comparing vaccine efficacy in the mouse vaginal challenge model. The data also support further investigation of ACAM529 for prophylaxis in human subjects.
- Published
- 2012
- Full Text
- View/download PDF
32. Tuberculous osteomyelitis of the foot in a haemodialysis patient.
- Author
-
Ersoy A, Cubukcuoglu T, Baloglu S, and Yalcinkaya U
- Published
- 2010
- Full Text
- View/download PDF
Catalog
Discovery Service for Jio Institute Digital Library
For full access to our library's resources, please sign in.